Phenylephrine Hydrochloride Injectable Solution
cGMP deviations.
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Product Mix up; Product was compounded in 250 mL 5% Dextrose instead of 250 mL 0.9% Sodium Chloride
Cause type: Other
Recalls whose stated reason does not fall into the categories above. See the recall's own reason text for the specifics. All other recalls.
Phenylephrine HCl 20 mg added to 0.9% Sodium Chloride 250mL Bag, Rx Only, Compounded by: Advanced Compounding Solutions, 4 Constitution Way Ste L Woburn, Massachusetts 01801-1042 United States, NDC 71546-451-25
Compare with the code on your package — it is the most precise check available.
Drug: Phenylephrine
Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
cGMP deviations.
Incorrect Product Formulation
CGMP Deviations
Sub-Potent Drug: Subpotent assay results during stability testing.
Lack of Assurance of Sterility: Leaking/damaged syringes.
CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.
CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.
CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.
CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.